GBS Inc. Reports First Quarter 2021 Financial Results and :

- Anticipate Emergency Use Submission for SARS-CoV-2Antibody Biosensor Test in the Second Half of 2021- - $14 Million in Cash, Cash Equivalents, and...

Related Keywords

, Emergency Use Submission , Biosensor Test , Second Half , Cash Equivalents , Marketable Securities , Provides Runway , Point Of Care Test Commercialization Ecosystem , Nasdaq Gbs , Cbs Inc , இரண்டாவது பாதி ,